Works matching AU Ghasemi, Soheil

Results: 7
    1

    Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial.

    Published in:
    Virology Journal, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12985-023-02121-z
    By:
    • Solaymani-Dodaran, Masoud;
    • Basiri, Pouria;
    • Moradi, Milad;
    • Gohari, Kimiya;
    • Sheidaei, Ali;
    • Ahi, Mohammadreza;
    • Ghafoori Naeeni, Farzad;
    • Ansarifar, Akram;
    • Rahimi, Zahra;
    • Gholami, Fatemeh;
    • Karimi Rahjerdi, Ahmad;
    • Hamidi Farahani, Ramin;
    • Naderi saffar, Kosar;
    • Ghasemi, Soheil;
    • Shooshtari, Ali;
    • Honari, Mohsen;
    • Mozafari, Ali;
    • Khodaverdloo, Samane;
    • Forooghizadeh, Mohsen
    Publication type:
    Article
    2

    Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial.

    Published in:
    Vaccines, 2022, v. 10, n. 11, p. 1800, doi. 10.3390/vaccines10111800
    By:
    • Ahi, Mohammadreza;
    • Hamidi Farahani, Ramin;
    • Basiri, Pouria;
    • Karimi Rahjerdi, Ahmad;
    • Sheidaei, Ali;
    • Gohari, Kimiya;
    • Rahimi, Zahra;
    • Gholami, Fateme;
    • Moradi, Milad;
    • Ghafoori Naeeni, Farzad;
    • Saffar, Kosar Naderi;
    • Ghasemi, Soheil;
    • Barati, Babak;
    • Moradi, Sohrab;
    • Monazah, Arina;
    • Pouranvari, Fatemeh;
    • Forooghizadeh, Mohsen
    Publication type:
    Article
    3

    Development of Inactivated FAKHRAVAC ® Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models.

    Published in:
    Vaccines, 2021, v. 9, n. 11, p. 1271, doi. 10.3390/vaccines9111271
    By:
    • Ghasemi, Soheil;
    • Naderi Saffar, Kosar;
    • Ebrahimi, Firooz;
    • Khatami, Pezhman;
    • Monazah, Arina;
    • Alizadeh, Ghorban-Ali;
    • Ettehadi, Hossein-Ali;
    • Rad, Iman;
    • Nojehdehi, Shahrzad;
    • Kehtari, Mousa;
    • Kouhkan, Fatemeh;
    • Barjasteh, Hesam;
    • Moradi, Sohrab;
    • Ghorbani, Mohammad-Hosein;
    • Khodaie, Ali;
    • Papizadeh, Moslem;
    • Najafi, Roghayeh;
    • Naghneh, Ehsan;
    • Sadeghi, Davood;
    • Karimi Rahjerdi, Ahmad
    Publication type:
    Article
    4
    5
    6

    Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18–70 years.

    Published in:
    BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08079-1
    By:
    • Gholami, Fatemeh;
    • Hamidi Farahani, Ramin;
    • Karimi Rahjerdi, Ahmad;
    • Ahi, Mohammadreza;
    • Sheidaei, Ali;
    • Gohari, Kimiya;
    • Rahimi, Zahra;
    • Ansarifar, Akram;
    • Basiri, Pouria;
    • Moradi, Milad;
    • Jahangiri, Arash;
    • Naderi, Kosar;
    • Ghasemi, Soheil;
    • Khatami, Pezhman;
    • Honari, Mohsen;
    • Khodaverdloo, Samane;
    • Shooshtari, Mohammad;
    • Mehr Azin, Hajar;
    • Moradi, Sohrab;
    • Shafaghi, Batool
    Publication type:
    Article
    7